A股異動丨華友鈷業連續跌停 大量應收賬款或與青山控股有關
格隆匯3月9日丨受到青山控股的重大利空傳言影響,千億大白馬華友鈷業(603799.SH)連續第二次跌停,報91.13元創去年6月以來新低,總市值1113億元。資料顯示,華友鈷業與青山控股關係密切,公司約80%的長期應收賬款可能與青山控股有關。截至2021年9月末,公司來自印尼緯達貝工業園有限公司、Veinstone Investment Limited的合計應收賬款佔長期應收款金額的83%。另外,2021年3月,青山控股與華友鈷業、中偉股份簽訂高冰鎳供應協議。三方約定,青山控股於2021年10月起的一年內,向華友鈷業供應6萬噸高冰鎳,向中偉股份供應4萬噸高冰鎳。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.